The FDA has declined to approve Columvi, in combination with the chemo regimen GemOx, for the treatment of second-line DLBCL patients who are not eligible for autologous stem cell transplant, Roche ...

US stocks turn down in early afternoon trade after FT says Trump wants an at least 15%-20% tariff on all EU goods. S&P 500, Nasdaq off record high.